Zivo Bioscience
(ZIVO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 98 | 317 | 1,225 | 24 | 1,008 |
| TOTAL | $187 | $332 | $1,315 | $57 | $1,056 |
| Non-Current Assets | |||||
| PPE Net | N/A | N/A | 0 | 6 | 13 |
| Other Non-Current Assets | 2,600 | 0 | 114 | 142 | 170 |
| TOTAL | $2,600 | $N/A | $114 | $148 | $183 |
| Total Assets | $2,787 | $332 | $1,429 | $206 | $1,239 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,171 | 2,426 | 17,165 | 1,416 | 1,285 |
| Accrued Expenses | 2,148 | 1,649 | 1,164 | 723 | 312 |
| Other current liabilities | 503 | 476 | 479 | 373 | 373 |
| TOTAL | $5,841 | $4,561 | $18,818 | $2,617 | $2,521 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 16,505 | 12,076 | 650 | 14,160 | 14,053 |
| TOTAL | $16,505 | $12,076 | $650 | $14,160 | $14,053 |
| Total Liabilities | $22,346 | $16,637 | $19,468 | $16,777 | $16,574 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 295 | 294 | 294 | 292 | 290 |
| Common Shares | 141 | 141 | 141 | 139 | 137 |
| Retained earnings | -67,659 | -63,812 | -59,932 | -57,064 | -55,636 |
| TOTAL | $-19,559 | $-16,305 | $-18,038 | $-16,571 | $-15,335 |
| Total Liabilities And Equity | $2,787 | $332 | $1,429 | $206 | $1,239 |